Event Detail (Archived)

Understanding the Latent HIV Reservoir to Advance Broadly Neutralizing Anti-HIV Antibodies as a Novel Therapeutic

  • This event already took place in November 2018
  • Carson Family Auditorium (CRC)

Event Details

Type
Other Seminars
Speaker(s)
Yehuda Cohen, M.D., instructor in clinical investigation, Laboratory of Molecular Immunology
Open to
Public
Contact
Adriana Barillas-Batarse
Phone
(212) 327-8293
Sponsor
Adriana Barillas-Batarse
(212) 327-8293
abarillas@rockefeller.edu

Related News

New engineered derivative of a natural molecule could translate into a powerful replacement for IVIG therapy for a wide array of autoimmune disorders

In experiments with mice, the new molecule accomplished the same job at a hundredth of the dose.

This new understanding of T cell receptors may improve cancer immunotherapies

Researchers discovered that a crucial first step in the signaling system operates differently than previously thought, an insight that could lead to the next generation of treatments.

What these scientists revealed about the structure of the T cell receptor could help resolve a decades-old debate over how T cells get activated

Researchers discovered new characteristics of a T cell receptor that’s essential to a variety of cutting-edge T cell immunotherapies.

Related Events

Microscale Biophysics of the Ocean: A Single-Cell Perspective on the Biological Carbon Pump

| CARSON FAMILY AUDITORIUM (CRC)

Liquid Biopsies in Pediatric Solid Tumors

| CARSON FAMILY AUDITORIUM (CRC)

Spying on the Immune System

| CASPARY AUDITORIUM
The Philip Levine Memorial Lecture